Vanguard Total Bond Market Index Fund ETF vs Charles River Laboratories Intl. Inc — how do they compare? Vanguard Total Bond Market Index Fund ETF trades at $72.25, while Charles River Laboratories Intl. Inc trades at $282 (market cap $13.46B). The key difference: Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Vanguard Total Bond Market Index Fund ETF nearer its low. Which is the better fit depends on your goals.
| BND | CRL | |
|---|---|---|
52-Week High | $75.17 | $282.00 |
52-Week Low | $72.15 | $145.57 |
Market Cap | — | $13.46B |
Sector | — | Health |
Enterprise Value | — | $16.30B |
Trailing returns across standard periods
This index measures the performance of a wide spectrum of public, investment-grade, taxable, fixed income securities in the US, including government, corporate, and international dollar-denominated bonds, as well as mortgage-backed and asset-backed securities-all with maturities of more than 1 year. All of the fund's investments will be selected through the sampling process, and at least 80% of its assets will be invested in bonds held in the index.
Read more on BND →Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →